Ultragenyx Pharmaceutical (RARE)
(Delayed Data from NSDQ)
$41.77 USD
+0.32 (0.77%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $41.75 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-1.63 | 2.06% |
Earnings Summary
For their last quarter, Ultragenyx Pharmaceutical (RARE) reported earnings of -$2.03 per share, missing the Zacks Consensus Estimate of -$1.72 per share. This reflects a negative earnings surprise of 18.02%. Look out for RARE's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.63 per share, reflecting a year-over-year increase of 27.56%.
Earnings History
Price & Consensus
Zacks News for RARE
Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
RARE: What are Zacks experts saying now?
Zacks Private Portfolio Services